131 related articles for article (PubMed ID: 11049982)
1. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice.
Heydemann A; Warming S; Clendenin C; Sigrist K; Hjorth JP; Simon MC
Blood; 2000 Nov; 96(9):3040-8. PubMed ID: 11049982
[TBL] [Abstract][Full Text] [Related]
2. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.
Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
Mol Cell Biol; 1990 Jun; 10(6):2521-7. PubMed ID: 2188092
[TBL] [Abstract][Full Text] [Related]
3. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.
Heydemann A; Juang G; Hennessy K; Parmacek MS; Simon MC
Mol Cell Biol; 1996 Apr; 16(4):1676-86. PubMed ID: 8657143
[TBL] [Abstract][Full Text] [Related]
4. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor.
Heydemann A; Boehmler JH; Simon MC
J Biol Chem; 1997 Nov; 272(47):29527-37. PubMed ID: 9368014
[TBL] [Abstract][Full Text] [Related]
5. Factors binding a non-classical Cis-element prevent heterochromatin effects on locus control region activity.
Harrow F; Amuta JU; Hutchinson SR; Akwaa F; Ortiz BD
J Biol Chem; 2004 Apr; 279(17):17842-9. PubMed ID: 14966120
[TBL] [Abstract][Full Text] [Related]
6. Function and factor interactions of a locus control region element in the mouse T cell receptor-alpha/Dad1 gene locus.
Ortiz BD; Harrow F; Cado D; Santoso B; Winoto A
J Immunol; 2001 Oct; 167(7):3836-45. PubMed ID: 11564801
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of c-Fes in myeloid leukemia cells.
He Y; Borellini F; Koch WH; Huang KX; Glazer RI
Biochim Biophys Acta; 1996 May; 1306(2-3):179-86. PubMed ID: 8634335
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.
Alcalay M; Antolini F; Van de Ven WJ; Lanfrancone L; Grignani F; Pelicci PG
Oncogene; 1990 Mar; 5(3):267-75. PubMed ID: 2179816
[TBL] [Abstract][Full Text] [Related]
10. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.
Roebroek AJ; Schalken JA; Onnekink C; Bloemers HP; Van de Ven WJ
J Virol; 1987 Jun; 61(6):2009-16. PubMed ID: 3553615
[TBL] [Abstract][Full Text] [Related]
11. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.
Keller P; Payne JL; Tremml G; Greer PA; Gaboli M; Pandolfi PP; Bessler M
J Exp Med; 2001 Sep; 194(5):581-9. PubMed ID: 11535627
[TBL] [Abstract][Full Text] [Related]
12. Isolation and structural analysis of murine c-fes cDNA clones.
Wilks AF; Kurban RR
Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
[TBL] [Abstract][Full Text] [Related]
13. DNase-I-hypersensitive sites located far upstream of the human c-sis/PDGF-B gene comap with transcriptional enhancers and a silencer and are preceded by (part of) a new transcription unit.
Dirks RP; Jansen HJ; Onnekink C; De Jonge RJ; Bloemers HP
Eur J Biochem; 1993 Sep; 216(2):487-95. PubMed ID: 8375387
[TBL] [Abstract][Full Text] [Related]
14. A central role for a single c-Myb binding site in a thymic locus control region.
Ess KC; Whitaker TL; Cost GJ; Witte DP; Hutton JJ; Aronow BJ
Mol Cell Biol; 1995 Oct; 15(10):5707-15. PubMed ID: 7565722
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of the murine C-FGR genomic locus: exons IB-XII.
Podhipleux N; Willman CL
Oncogene; 1995 Aug; 11(4):781-4. PubMed ID: 7651742
[TBL] [Abstract][Full Text] [Related]
16. Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity.
Giraldo P; Martínez A; Regales L; Lavado A; García-Díaz A; Alonso A; Busturia A; Montoliu L
Nucleic Acids Res; 2003 Nov; 31(21):6290-305. PubMed ID: 14576318
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.
Volpi L; Beghini A; Rossi D; Larizza L
Mamm Genome; 1996 Sep; 7(9):682-5. PubMed ID: 8703122
[TBL] [Abstract][Full Text] [Related]
18. Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene.
Wang SJ; Greer P; Auerbach R
In Vitro Cell Dev Biol Anim; 1996 May; 32(5):292-9. PubMed ID: 8792159
[TBL] [Abstract][Full Text] [Related]
19. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice.
Hackenmiller R; Kim J; Feldman RA; Simon MC
Immunity; 2000 Sep; 13(3):397-407. PubMed ID: 11021537
[TBL] [Abstract][Full Text] [Related]
20. Vascular defects in gain-of-function fps/fes transgenic mice correlate with PDGF- and VEGF-induced activation of mutant Fps/Fes kinase in endothelial cells.
Sangrar W; Mewburn JD; Vincent SG; Fisher JT; Greer PA
J Thromb Haemost; 2004 May; 2(5):820-32. PubMed ID: 15099290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
